Isomorphic Labs

Growth Healthcare AIAI for ScienceFoundation ModelsResearch

Founded: 2021
Headquarters: London
Employees: 201-500
UK presence: UK headquartered

Applies AI to drug discovery, using models descended from AlphaFold to predict how molecules behave and design new medicines. Headquartered in London as an Alphabet company spun out of DeepMind.

Website

What they build

Isomorphic Labs Drug Design Engine Platform

Suite of AI models for drug design that predict molecular structures, binding affinity and potential toxicity to support therapeutic development.

The story so far

£1.6B raised across 1 round we've tracked.

4 September 2026

Hassabis steps back from DeepMind: what it means for the UK's flagship lab
20 August 2026

UK's Sovereign AI fund now backs 12 companies, and wants to be their customer
7 August 2026

AI took more than 70% of UK venture funding in the first half of 2026
12 May 2026

Isomorphic Labs raises $2.1B to turn AlphaFold into medicines Series B · £1.6B

Basecamp Research
Google DeepMind
Latent Labs
CuspAI

What they build

The story so far

Related companies